Recent Advances in Mesoporous Silica Nanoparticles Delivering siRNA for Cancer Treatment
Pharmaceutics · 17.10.2023 · 15 (10) · 2483
DOI: 10.3390/pharmaceutics15102483 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 17.10.2023. Verfasst von Xiaowei Xie und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of China, National Science Foundation of China.
Abstract (Originalsprache)
Silencing genes using small interfering (si) RNA is a promising strategy for treating cancer. However, the curative effect of siRNA is severely constrained by low serum stability and cell membrane permeability. Therefore, improving the delivery efficiency of siRNA for cancer treatment is a research hotspot. Recently, mesoporous silica nanoparticles (MSNs) have emerged as bright delivery vehicles for nucleic acid drugs. A comprehensive understanding of the design of MSN-based vectors is crucial for the application of siRNA in cancer therapy. We discuss several surface-functionalized MSNs’ advancements as effective siRNA delivery vehicles in this paper. The advantages of using MSNs for siRNA loading regarding considerations of different shapes, various options for surface functionalization, and customizable pore sizes are highlighted. We discuss the recent investigations into strategies that efficiently improve cellular uptake, facilitate endosomal escape, and promote cargo dissociation from the MSNs for enhanced intracellular siRNA delivery. Also, particular attention was paid to the exciting progress made by combining RNAi with other therapies to improve cancer therapeutic outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of China
- National Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Xie, X., Yue, T., Gu, W., Cheng, W., He, L., Ren, W., Li, F., & Piao, J. G. (2023). Recent Advances in Mesoporous Silica Nanoparticles Delivering siRNA for Cancer Treatment. Pharmaceutics, 15(10), 2483. https://doi.org/10.3390/pharmaceutics15102483
Vancouver
Xie X, Yue T, Gu W, Cheng W, He L, Ren W, et al. Recent Advances in Mesoporous Silica Nanoparticles Delivering siRNA for Cancer Treatment. Pharmaceutics. 2023;15(10):2483. doi:10.3390/pharmaceutics15102483
BibTeX
@article{Xie2023,
author = {Xie, Xiaowei and Yue, Tianxiang and Gu, Wenting and Cheng, WeiYi and He, Li and Ren, WeiYe and Li, Fanzhu and Piao, Ji-Gang},
title = {Recent Advances in Mesoporous Silica Nanoparticles Delivering siRNA for Cancer Treatment},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {10},
pages = {2483},
doi = {10.3390/pharmaceutics15102483}
}
EUVIMED